• 中文
  • 登录
  • 联系我们
×
目录产品 » SARS-CoV-2 Spike protein (RBD, K417N, Avi & His Tag)
SARS-CoV-2 Spike Protein (RBD, K417N, Avi & His Tag)

Immobilized ACE-2 Fc Chimera, Human (Cat. No. Z03484) at 2 μg/mL can bind SARS-CoV-2 Spike protein (RBD, K417N, Avi & His Tag) (Cat. No. Z03536) with a serial dilution.
THETM His Tag Antibody [HRP], mAb, Mouse (Cat.No.A00612) is used as a secondary antibody (0.2 μg/mL).

SARS-CoV-2 Spike Protein (RBD, K417N, Avi & His Tag)

Lane 1: 1μg of SARS-CoV-2 Spike protein (RBD, K417N, Avi & His Tag), reducing(R)
> 95% as analyzed by SDS-PAGE

SARS-CoV-2 Spike protein (RBD, K417N, Avi & His Tag)

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Spike Protein is composed of S1 domain and S2 domain. This mutation corresponds to one of the three mutations found in the RBD domain of the South Africa SARS-CoV-2 virus (variant B.1.351).
Z03536
¥3800

联系我们
Species SARS-CoV-2
Protein Construction
Spike RBD [Arg319-Ser591 (K417N)]
Accession # P0DTC2
Avi Poly-His
N-term C-term
Purity > 90% as analyzed by SDS-PAGE
Endotoxin Level < 0.2 EU/μg of protein by gel clotting method
Biological Activity SARS-CoV-2 Spike protein (RBD, K417N, Avi & His Tag) can bind to human ACE2 (Cat. No.: Z03484) in functional ELISA assay.
Expression System 293 Cells
Theoretical Molecular Weight 30 kDa
Formulation Supplied as a solution in PBS, pH 7.4.
Concentration Please refer to the COA for the specific lot.
Storage & Stability Upon receiving, this product remains stable for up to 6 months at -20°C or below. Avoid repeated freeze-thaw cycles.

  • SARS-CoV-2 Spike Protein (RBD, K417N, Avi & His Tag)
  • SARS-CoV-2 Spike Protein (RBD, K417N, Avi & His Tag)

    Immobilized ACE-2 Fc Chimera, Human (Cat. No. Z03484) at 2 μg/mL can bind SARS-CoV-2 Spike protein (RBD, K417N, Avi & His Tag) (Cat. No. Z03536) with a serial dilution.
    THETM His Tag Antibody [HRP], mAb, Mouse (Cat.No.A00612) is used as a secondary antibody (0.2 μg/mL).

  • SARS-CoV-2 Spike Protein (RBD, K417N, Avi & His Tag)
  • SARS-CoV-2 Spike Protein (RBD, K417N, Avi & His Tag)

    Lane 1: 1μg of SARS-CoV-2 Spike protein (RBD, K417N, Avi & His Tag), reducing(R)
    > 95% as analyzed by SDS-PAGE


Target Background SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Spike Protein is composed of S1 domain and S2 domain. This mutation corresponds to one of the three mutations found in the RBD domain of the South Africa SARS-CoV-2 virus (variant B.1.351).
Synonyms SARS-CoV-2 SP RBD, K417N; 2019-nCoV SP RBD, K417N

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.